Francisco Silva
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BioRestorative Therapies, Inc. (BRTX)
Source not stated
Current -
2020-01-01–2026-06-11
-
2020-01-01–2026-06-11
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $514,583 | $1,227,083 |
| 2023 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $454,167 | $1,204,167 |
| 2022 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $375,000 | $427,364 |
| 2021 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $259,375 | $21,325,864 |
| 2020 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $207,553 | $207,553 |
| 2019 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $287,500 | $287,500 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.